Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.640
-0.090 (-5.20%)
At close: Aug 26, 2026, 4:00 PM EDT
1.680
+0.040 (2.44%)
Pre-market: Aug 27, 2026, 9:25 AM EDT
Veraxa Biotech AG Market Cap
Veraxa Biotech AG has a market cap or net worth of $41.36 million as of August 27, 2026. Its market cap has decreased by -87.45% in one year.
Market Cap
41.36M
Enterprise Value
36.39M
1-Year Change
-87.45%
Ranking
Category
Stock Price
$1.64
ChartMarket Cap Chart
Since September 30, 2024, Veraxa Biotech AG's market cap has decreased from $315.30M to $41.36M, a decrease of -86.88%. That is a compound annual growth rate of -65.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 41.36M | -87.74% |
| Dec 31, 2025 | 337.44M | 6.49% |
| Dec 30, 2024 | 316.88M | 0.50% |
| Sep 30, 2024 | 315.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 46.90M |
| Metagenomi Therapeutics | 46.09M |
| Grace Therapeutics | 45.23M |
| Filana Therapeutics | 44.66M |
| Karyopharm Therapeutics | 44.46M |
| Mereo BioPharma Group | 44.39M |
| Tevogen | 43.63M |
| Actuate Therapeutics | 42.75M |